U.S. Acute External Ventricular Drain Market Size Worth USD 170.39 Million by 2034 | CAGR: 7.8%

The U.S. acute external ventricular drain market size is expected to reach USD 170.39 Million by 2034, according to a new study by Polaris Market Research. The report “US Acute External Ventricular Drain Market Size, Share, Trends, & Industry Analysis Report By Patient Type (Pediatric and Adult), By Application, and By Country – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The US acute external ventricular drain (EVD) market is growing significantly as hospitals and trauma centers focus more on advanced brain care technologies. EVD systems are now considered an essential part of managing patients with brain injuries, helping doctors safely remove excess cerebrospinal fluid and reduce pressure in the brain. These systems are crucial in intensive care units, enabling timely and precise management of elevated intracranial pressure. 

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/us-acute-external-ventricular-drain-market/request-for-sample

Companies in the US are developing smarter medical devices that are easier to use, reduce infection risks, and improve safety. The adoption of advanced EVD technologies across hospitals is increasing the demand for modern drainage systems. The growing involvement of neurosurgical teams and healthcare providers made these systems a critical part of emergency and critical care protocols, contributing to steady market growth across the country.

Top of FormU.S. Acute External Ventricular Drain Market Report Highlights

• Based on patient type, the adult segment dominated the market in 2024. This is attributed to the higher incidence of traumatic brain injuries, intracranial hemorrhages, and age-associated neurological disorders within this demographic.
• In terms of application, the subarachnoid hemorrhage segment is projected to experience the highest growth rate in the coming years. This accelerated growth stems from cases involving aneurysmal ruptures and spontaneous bleeding into the subarachnoid space
• A few global key market players include Abbott Laboratories, Anuncia Medical, Inc., B. Braun Medical Inc. (Aesculap, Inc.), Becton, Dickinson and Company, Boston Scientific Corporation, Fuji Systems USA, Inc., ICU Medical, Inc., Integra LifeSciences Corporation, Medtronic, Inc., Natus Medical Incorporated, Smiths Medical, Inc., Stryker Corporation, Teleflex Incorporated, Thermo Fisher Scientific Inc., and Zimmer Biomet Holdings, Inc.

Polaris Market Research has segmented the market report on the basis of patient type, application, and region:

By Patient Type Outlook (Revenue, USD Million, 2020–2034)

• Pediatric
• Adult

By Application Outlook (Revenue, USD Million, 2020–2034)

• Traumatic Brain Injury
• Subarachnoid Hemorrhage
• Intracerebral Hemorrhage
• Other Non-traumatic Hydrocephalus Conditions